p53 expression and DNA ploidy pattern in Egyption colorectal carcinoma

Hepato-Gastroenterology

Volumn 49, Issue 47, 2002, Pages 1225-1229

  Zalata, Khaled R ^a   Leech, Stephen H ^a   Ming, Si Chun ^a   Nasif, Wesam A ^a   Nada, Nadia A ^a   Mohamed, Ibrahim E ^a   Atallah, Abdelfattah M ^a   Gad El Hak, Nabil A ^a  

^a MANSOURA UNIVERSITY   (Egypt)

Author keywords

Colorectal carcinoma; Flow cytometry; Immunohistochemistry; p53

Indexed keywords

MONOCLONAL ANTIBODY; PROTEIN P53;

ADULT; AGED; ANEUPLOIDY; ARTICLE; COLON RESECTION; COLORECTAL CARCINOMA; CONTROLLED STUDY; DNA CONTENT; DNA DETERMINATION; EGYPT; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; TETRAPLOIDY; TUMOR LOCALIZATION;

ADENOCARCINOMA; ADENOCARCINOMA, MUCINOUS; ADULT; AGED; AGED, 80 AND OVER; COLORECTAL NEOPLASMS; EGYPT; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION; GENES, P53; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; PLOIDIES;

EID: 0036377921     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Database of p53 gene somatic mutations in human tumors and cell lines
2. Cell cycle control and cancer
3. The 1993 Walter Hubert Lecture: The role of the p53 tumor suppressor gene in tumorigenesis
4. Protein p53 in gastric carcinoma: Clinical use of cancer research on neoplasms
5. p53 in tumor pathology: Can we trust immunohistochemistry? - Revisted
6. An evaluation of six antibodies for immunohistochemistry of mutant p53 gene product in archival colorectal neoplasms
7. Participation of P53 protein in the cellular response to DNA damage
8. A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in Ataxia-telangiectasia
9. The p53 - mdm-2 autoregulatory feedback loop
10. WAF1, a potential mediator of p53 tumor suppression
11. Cyclins and cancer II: Cyclin D and cyclin-dependant kinase inhibitors come of age
12. Association of p53 mutations with short survival in colorectal cancer
13. Molecular biology of colorectal neoplasia
14. A model of DNA aneuploidization and evolution of colorectal cancer
15. p53 expression in colorectal cancer. Relation to tumor type, DNA ploidy pattern and short term survival
16. Stabilized P53 facilitates aneuploid clonal divergence in colorectal cancer
17. Correlation between DNA content and p53 detection in colorectal cancer
18. Simultaneous monitoring of P53 protein and DNA content of colorectal adenocarcinomas by flow cytometry
19. Mutation of the p53 gene precedes aneuploid clonal divergence in colorectal carcinoma
20. A universal staging system for cancer of the colon and rectum
21. Analysis of p53 expression in human tumors: An antibody raised against human p53 expressed in Escherichia coli
22. Method for analysis of cellular DNA content of Paraffin-embedded pathological material using flow cytometery
23. DNA analysis from paraffin-embedded blocks
24. HLA antigens and disease: Statistical and genetical considerations
25. Tissue-specific markers in flow cytometry of urological cancers, III. Comparing chromosomal and flow cytometric DNA analysis of bladder tumors
26. DNA content and genetic evolution of human colorectal adenocarcinoma. A study of flow cytometry and cytogenetic analysis
27. Ordering S-phase and M-phase in the cell cycle
28. Roles to replicate by
29. Closing the cell cycle in yeast: G2 cyclin proteolysis initiated at mitosis persists until the activation of G1 cyclins in the next cycle
30. Correlation between DNA content and p53 deletion in colorectal cancer
31. Evasion of p53-mediated growth control occurs by three alternative mechanisms in transformed thyroid epithelial cells
32. Human cyclin E, a nuclear protein essential for the G1- to S-phase transition
33. Checkpoint regulates the rate of progression through S phase in S. Cervisiae in response to DNA damage
34. Discrimination of G2 and mitotic cells by flow cytometry based on different of cyclins A and B1
35. Creative blocks: Cell-cycle checkpoints and feedback control
36. Telomere reduction in human colorectal carcinoma and with aging
37. Evidence for a second cell cycle block at G2/M by p53
38. p53 mutations and DNA ploidy in colorectal adenocarcenomas
39. Comparison of DNA content in non-Hodgkin's lymphoma as measured by flow cytometry and cytogenetics